Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaccines

Showing results (431-440 of 10,021) with videos related to

Pageof 1,003
Sort By:
Vaccines|June 3, 2020
Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune ResponsesMin Ja Lee, Hyundong Jo, So Hui Park, et al.
Vaccines|September 13, 2016
Neutrophils and Granulocytic MDSC: The Janus God of Cancer ImmunotherapySerena Zilio, Paolo Serafini
Vaccines|September 15, 2016
Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune ResponsesJohanna Poecheim, Christophe Barnier-Quer, Nicolas Collin, et al.
Vaccines|July 26, 2018
Avian Influenza A Virus Pandemic Preparedness and Vaccine DevelopmentRory D de Vries, Sander Herfst, Mathilde Richard
Vaccines|July 26, 2018
<i>Listeria monocytogenes</i> as a Vector for Cancer Immunotherapy: Current Understanding and ProgressJohn C Flickinger, Ulrich Rodeck, Adam E Snook
Vaccines|July 20, 2018
Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCsDafni Chondronasiou, Tracy-Jane T H D Eisden, Anita G M Stam, et al.
Vaccines|August 2, 2018
Activation-induced Markers Detect Vaccine-Specific CD4⁺ T Cell Responses Not Measured by Assays Conventionally Used in Clinical TrialsGeorgina Bowyer, Tommy Rampling, Jonathan Powlson, et al.
Vaccines|August 15, 2018
The Vestigial Esterase Domain of Haemagglutinin of H5N1 Avian Influenza A Virus: Antigenicity and Contribution to Viral PathogenesisZhiqiang Zheng, Subha Sankar Paul, Xiaobing Mo, et al.
Vaccines|May 25, 2017
The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United StatesBlythe J S Adamson, Josh J Carlson, James G Kublin, et al.
Vaccines|April 28, 2018
Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist PerspectiveSurender Khurana
Pageof 1,003

Showing results (431-440 of 10,021) with videos related to

Sort By:
Pageof 1,003
Vaccines|June 3, 2020
Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune ResponsesMin Ja Lee, Hyundong Jo, So Hui Park, et al.
Vaccines|September 13, 2016
Neutrophils and Granulocytic MDSC: The Janus God of Cancer ImmunotherapySerena Zilio, Paolo Serafini
Vaccines|September 15, 2016
Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune ResponsesJohanna Poecheim, Christophe Barnier-Quer, Nicolas Collin, et al.
Vaccines|July 26, 2018
Avian Influenza A Virus Pandemic Preparedness and Vaccine DevelopmentRory D de Vries, Sander Herfst, Mathilde Richard
Vaccines|July 26, 2018
<i>Listeria monocytogenes</i> as a Vector for Cancer Immunotherapy: Current Understanding and ProgressJohn C Flickinger, Ulrich Rodeck, Adam E Snook
Vaccines|July 20, 2018
Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCsDafni Chondronasiou, Tracy-Jane T H D Eisden, Anita G M Stam, et al.
Vaccines|August 2, 2018
Activation-induced Markers Detect Vaccine-Specific CD4⁺ T Cell Responses Not Measured by Assays Conventionally Used in Clinical TrialsGeorgina Bowyer, Tommy Rampling, Jonathan Powlson, et al.
Vaccines|August 15, 2018
The Vestigial Esterase Domain of Haemagglutinin of H5N1 Avian Influenza A Virus: Antigenicity and Contribution to Viral PathogenesisZhiqiang Zheng, Subha Sankar Paul, Xiaobing Mo, et al.
Vaccines|May 25, 2017
The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United StatesBlythe J S Adamson, Josh J Carlson, James G Kublin, et al.
Vaccines|April 28, 2018
Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist PerspectiveSurender Khurana
Pageof 1,003